SignalCorporate
ASTELLAS PHARMA ADR GAAP EPS OF ¥78.96, REVENUE OF ¥640.91B; REAFFIRMS FY 2027 OUTLOOK - SEEKINGALPHA
ASTELLAS PHARMA ADR GAAP EPS OF ¥78.96, REVENUE OF ¥640.91B; REAFFIRMS FY 2027 OUTLOOK - SEEKINGALPHA
What changed
ASTELLAS PHARMA ADR GAAP EPS OF ¥78.96, REVENUE OF ¥640.91B; REAFFIRMS FY 2027 OUTLOOK - SEEKINGALPHA
Why it matters
ASTELLAS PHARMA ADR GAAP EPS OF ¥78.96, REVENUE OF ¥640.91B; REAFFIRMS FY 2027 OUTLOOK - SEEKINGALPHA — impact context not separately stored; see What changed.
← Dashboard
Aug 05, 2026 06:56 AM ET